INSIGHTS ON FACILITY DESIGN

  • EMPQ And Validation Support Services
    2/21/2024

    A growing pharmaceutical/biotech company hired a global consulting firm for a project that required EMPQ services for qualification activities on a newly completed aseptic processing suite.

  • SAP S4HANA Implementation: Commissioning, Qualification, And Validation
    2/20/2024

    Explore how CAI helped the company to navigate complications when implementing SAP and how new solutions are being developed, validated, and implemented to establish this new global ERP system.

  • Consolidating The Supply Chain For mRNA
    2/12/2024

    Learn about the first end-to-end cGMP facility that was developed for mRNA manufacturing to address the shortage of CDMOs and the inadequate and inefficient supply chain options for sourcing GMP mRNA.

  • Mabion: Your Biologics CDMO
    2/8/2024

    Learn about Mabion's capabilities as a CDMO, its commitment to quality and customer satisfaction, and the crucial role the company plays in the drug development and manufacturing space.

  • Multimodal R&D Management With Incyte's Jim Lee, M.D., Ph.D.
    1/18/2024

    Success at multimodal, multi-indication, deep-pipelined Incyte—where commercial operations are as familiar as pre-discovery activity is—begins at the earliest opportunity to achieve research and discovery efficiencies.

FACILITY DESIGN SOLUTIONS

  • Review how a comprehensive cGMP manufacturing facility is poised to support the development and manufacture of your mammalian cell program.

  • EirGenix provides client-oriented contract development and manufacturing services for biologics, especially monoclonal antibodies and biosimilars. Combining the capabilities of EirGenix’s strategic partner, Formosa Laboratories, Inc, a high potency API manufacturer, we offer integrated services for Antibody Drug Conjugate (ADC) development and manufacturing.

  • Learn how our robust analytical and GMP manufacturing services can enable cost-effective, flexible, and accelerated support for pre-clinical to commercial supply.

  • Learn how our 4,000-square-foot cGMP manufacturing site is purpose-built to support your microbial program from pre-clinical to commercial manufacturing.

  • Learn how a reliable and agile partner that enables seamless scalability and accelerated development can help you navigate the journey from research and development to clinical trials and beyond.